Gardner, MA (PRWEB) May 05, 2014
New England Peptide, Inc. (NEP), a worldwide leader in the production of custom peptides and antibodies, announced today that it opened a second business location in Cambridge, MA.
The expansion, which is located at One Broadway in Cambridge, MA, is located in the heart of one of the world's densest biotech/pharmaceutical areas. The business office is currently open.
"Our recent expansion into Cambridge will allow NEP to offer an even higher level of service to our research customers. The new office is located directly in the nerve center of multiple reputable research organizations", said Sam Massoni, CEO of NEP. "This is another example of our commitment to provide exceptional personalized service. As a premium provider of peptides and antibodies, our customers rely on us for high level design and advice, and so we've created another avenue to promote more face to face interaction."
NEP manufactures its products in central Massachusetts, and has plans to keep all manufacturing in the United States going forward. "With the confidence of a strong regulatory and legal environment within Massachusetts, our customers know they will be receiving high quality products for their research. Quality is still the most important criteria for ordering custom peptides and antibodies, and for 16 years NEP has been the leader of the pack", commented Rick Perullo, Business Development Manager at NEP.
About New England Peptide (NEP)
New England Peptide, founded in 1998, designs and manufactures peptides, polyclonal and monoclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, Mass., the company’s chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications. More information on NEP can be found at http://www.newenglandpeptide.com.